Funds

Medic, 55, raises funds for MS treatment in Mexico after being told she’s ‘too old’ for therapy in the UK


When Lisa Sabotig was diagnosed with multiple sclerosis (MS) at 55, she was shocked to discover she was too old for potentially life-changing treatment on the NHS. So, she and her husband Jacob set about raising funds for her to have the therapy in Mexico in a bid to keep her mobile and out of a wheelchair.

MS is a lifelong condition that affects the brain and nerves. According to the MS Society, hematopoietic stem cell transplant (HSCT) is a ‘hugely promising treatment for MS, but it is also very intense’ and only available to people under 45 on the NHS. It works by resetting the immune system and stopping inflammation through chemotherapy and stem cell replacement.



Lisa’s first symptoms were that she woke up one day unable to move the left side of her body but she recovered and it was thought to be a ‘one off’. Ten months later, she suffered agonising pain in her right eye and severe stabbing and burning pains all through her body. She was diagnosed with MS in November 2021 and started researching treatment straight away.

Read more: Eye pain turned out to be something much more serious for Birmingham medic

“MS is unpredictable and brutal,” said Lisa, from Edgbaston, who has dedicated her life to caring for children and young people as a psychologist. “MS fatigue has been my biggest enemy, it’s not like any tiredness I have ever known before. Everything must grind to a halt. I wear a brace and use my walking stick on bad days.

“After the shellshock of diagnosis, I settled on HSCT after many months of reading but we felt that raising the money would be an impossibility, simply insurmountable. We just couldn’t do this on our own.

“We talked through how we could plan a series of fundraising events through the year. We worked so hard at bringing our communities together and the love, support and generosity they’ve shown has been utterly breathtaking. Their incredible help gave us so much hope. Slowly but surely over 2022 and into January 2023 we moved steadily towards our target.”



Source link

Leave a Response